Skip to main content

Table 2 Lung cancers with germline cancer predisposing genes detected and somatic EGFR mutation information in lung cancer-clustering families

From: Potential genetic modifiers for somatic EGFR mutation in lung cancer: a meta-analysis and literature review

Germline genes or loci

Germline mutations

Case #

Family #

Relation

Sex

Age

Ethnicity

Smoking

Histology

Somatic EGFR mutation

Comment

Ref.

EGFR

p.T790 M

1

1

Proband

M

50

White

S

5 × ADCs

2 × L858R, 1 × 19del, 2 × WT

Mother (F, 62, BAC); Maternal grandfather (M, 72, BAC); Maternal great uncle (M, 60s, BAC); Brother (51, male, multi-nodules) and Sister (48, female, unaffected) carried germline EGFR p.T790 M

Bell, et al. 2005 [36]

  

2

1

Brother

M

55

White

S

ADC

G719A

  

EGFR

p.T790 M

3

2

Proband

F

72

NR

NS

1 × ADC + 1× BAC + 1 × LCC

3 × WT

Sister affected with lung cancer

Prudkin, et al. 2009 [37]

EGFR

p.T790 M

4

3

Proband

F

62

NR

NS

ADC

WT

Mother had lung cancer

Prudkin, et al. 2009 [37]

EGFR

p.T790 M

5

4

Proband

F

72

White

NS

ADC

19del

Inconsistent records in the pedigree (aged 73 and having SCC)

Tibaldi, et al. 2011 [38]

  

6

4

Sister

F

74

White

NS

NSCLC

WT

Exon 20 was not examined due to insufficient tumour tissue.

EGFR

p.T790 M

7

5

Proband

F

70

NR

S

ADC

WT

Father (M, 60s, smoker, lung cancer); brother (male, 62, smoker, throat cancer); Proband had somatic K-RAS mutation.

Thomas, et al. 2013 [39]

EGFR

p.T790 M

8

6

Proband

F

58

NR

S

ADC

L858R

Mother (female, 70s, non-smoker, BAC); brother (male, 45, ADC), brother (male, 51, non-smoker, bilateral lung nodules of uncertain cause at follow-up)

Thomas, et al. 2013 [39]

EGFR

p.T790 M

9

7

Proband

F

29

White

LS

ADC

L858R

Proband also had multiple lesions including AAH, AIS and MIA. Fourteen carriers with known, obligate or assumed mutations in the family pedigree; in these carriers, 4 had lung cancer. In Five unaffected mutation carriers, four had multiple nodules and the other one had single sub-cm solid nodule.

Gazdar, et al. 2014 [40]

EGFR

p.T790 M

10

8

Proband

F

44

NR

NS

7 × ADCs

4 × L858R, 2 × 19del, 1 × WT

The EGFR wild-type ADC had somatic ARID1A p.K1938 N. Family history of breast and ovarian cancer in maternal relatives (2nd-degree); germline BRCA2 p.L459S variant of uncertain significance detected. Mother with metastatic ADC (germline T790 M carrier, unknown age, BRCA1/2 not detected); Daughter carried germline T790 M.

Yu, et al. 2014 [41]

EGFR

p.T790 M

11

9

Proband

F

34

White

NS

ADC

L858R

Family history of lung and other cancers (paternal relatives); no germline EGFR T790 M status available in other members

Lou, et al. 2016 [42]

EGFR

p.R776H

12

10

Proband

F

57

White

NS

NSCLC

G719A

NSCLC with squamous component inside. Only a brother detected and did not carry the germline R776H mutation.

Van Noesel, et al. 2013 [43]

  

13

10

Daughter

F

36

White

NS

SCC

G719S

 

EGFR

p.V769 M

14

11

Proband

M

57

Jewish

S

5 × ADCs

2 × G719A, 2 × (G719C + S768I), 1 × G719S

Family history of other cancers (breast and ovarian cancers in the 2nd-degree maternal relatives), did not examine BRCA1/2; the proband also present several small lung nodules in the lung postoperatively

Hellman, et al. 2017 [44]

EGFR

p.V843I

15

12

Proband

F

70

Asian

UK

3 ADCs + 4 BACs + 3 AAHs

3 × L858R (1 ADC, 1 BAC, 1 AAH), 2 × L861Q (2 ADCs)

Other 5 lesions haven’t been examined. Father and a brother died of lung cancer. A healthy sister and another unaffected brother carried the germline V831I mutation.

Ikeda, et al. 2008 [45]

EGFR

p.V843I

16

13

Proband

F

78

Asian

UK

ADC

L858R

Aunt had ADC at 70 (germline not examined). A nephew had non-Hodgkin’s lymphoma at 12 (germline V843I negative). A healthy daughter carried germline V843I mutation.

Ohtsuka, et al. 2011 [46]

  

17

13

Mother

F

70

Asian

UK

ADC

L858R

  

18

13

Brother

M

41

Asian

UK

ADC

L858R

EGFR

p.V834 L

19

14

Proband

F

57

Surinam

S

ADC

L858R

A daughter carried germline V834 L; Father died of massive hemoptysis of unknown cause.

Van der Leest, et al. 2018 [47]

  

20

14

Brother

M

57

Surinam

S

NSCLC

L858R

  

21

14

Sister

F

46

Surinam

NS

NSCLC

L858R

  

22

14

Daughter

F

42

Surinam

NS

NSCLC

L858R

HER2

p.G660D

23

15

Proband

F

44

Asian

LS

Multi-ADCs

WT

HER2 Family history of lung cancers among multiple maternal members; Daughter with germline G660D, and CT showed multiple GGNs in bilateral lungs at 30 (light smoker).

Yamamoto, et al. 2014 [48]

  

24

15

Mother

F

74

Asian

NS

Multi-ADCs

WT

 

MET

p.N375K

25

16

Proband

F

75

Asian

NS

ADC

L858R

Another sister (never-smoker) clinically diagnosed with lung cancer at 80.

Tode, et al. 2017 [49]

  

26

16

Sister

F

63

Asian

NS

ADC

19del

  

27

16

Sister

F

63

Asian

LS

ADC

L858R

CHEK2

p.R474C (homozygous)

28

17

Proband

M

60

Asian

NS

Multi-ADCs,

NR

Proband: colon and prostate cancer affected. Father (60 year): prostate and gastric cancer; Mother (79 year): solitary lung cancer; A son (1 year 10 moths): neuroblastoma.

Kukita, et al. 2016 [50]

  

29

17

Sister

F

60

Asian

NS

7 ADCs,

L858R or 19del

Uterine myoma and breast cancer affected

 

BRCA2

c.9641insT

30

18

Proband

M

43

White

NS

ADC

Exon 20ins

Family history of breast cancer in maternal relatives and lung cancer in maternal grandfather (never smoker)

Marks, et al. 2008 [51]

BRCA2

c.8867del5

31

19

Proband

M

74

White

LS

ADC

19del

Family history of breast or ovarian cancers in daughter, mother and maternal aunt. Daughter carried germline BRCA2 c.8867del5 mutation.

Marks, et al. 2008 [51]

TP53

p.R273H

32

20

Proband

F

34

NR

NS

ADC

19del

Proband: breast cancer affected at 30 (somatic HER2+, EGFR-). Mother with bilateral breast cancer at 35; Sister 1 with breast liposarcoma at 26 (germline TP53 p.R273H); Sister 2 with breast cancer at 33 (germline TP53 p.R273H); maternal grandmother with breast cancer at early 40s; Brother unaffected (germline TP53 p.R273H); Sister 3 without germline TP53 mutation; all without germline BRCA1/2.

Bemis, et al. 2007 [52]

TP53

p.G245S

33

21

Proband

F

43

Hispanic

NS

ADC

L858R

Concurrent somatic HER2 p.S310F. Germline BRCA1/2 negative. Affected breast cancer at 44, gluteal schwannoma at 46 and atypical leiomyoma. Sister and Aunt with breast cancer at 40s; Cousin with brain tumour at a young age; Mother with leukaemia.

Jia, et al. 2014 [53]

TP53

exon 19 deletion

34

22

Proband

F

51

White

NS

ADC

L858R

Proband: bilateral breast cancers and malignant fibrous histiocytoma affected. Mother, maternal aunts, two first cousins and maternal grandmother died of early-onset cancers (< 60 years)

Michalarea, et al. 2014 [54]

TP53

p.H179Y

35

23

Proband

M

55

NR

NS

ADC

19del

T790 M mutation (post-TKI) detected; No somatic alterations on HER2, PI3KCA, BRAF, KRAS or ALK genes. Descendants affected with unusual childhood tumours.

Ricordel, et al. 2015 [55]

TP53

p.R273H

36

24

Proband

F

57

NR

NS

ADC

L858R

Affected with breast cancer as well. No somatic alterations on HER2, PI3KCA, BRAF, KRAS or ALK genes. Daughter affected with corticosurrenaloma.

Ricordel, et al. 2015 [55]

TP53

p.G245S

37

25

Proband

F

30

NR

NR

ADC

19 del

Daughter affected with sarcoma at 10. Another two children are carriers.

Pathak, et al. 2018 [56]

TP53/CDH1

p.R196a; CDH1 p.N570=

38

26

Proband

F

26

Hispanic

NS

3 ADC

1 × 19del

Proband: the other two ADCs with EGFR amplification and PIK3CA p.E545K. Intra-alveolar lung tumour spread with K-RAS p.G12C + BRAF p.L597 V; Osteosarcoma affected at 12 (somatic PIK3CA p.E545K + K-RAS p.G12S + CDH1 p.A617T). Mother with breast cancer at 32; Maternal Uncle with facial and orbitary chondrosarcoma at 14 and diffuse gastric cancer at 24; Maternal Uncle with anaplastic astrocytoma at 13; Maternal Cousin with diffuse gastric cancer at 36 (germline CDH1 p.Leu721Val); Maternal Cousin with EGFR-mutated lung cancer at 26; Maternal Grandmother with breast cancer at 50, melanoma at 44 and colon cancer at 50; Paternal Aunt with breast cancer at 48.

Cardona, et al. 2018 [57]

TP53

p.R248W

39

27

Proband a

F

34

NR

NS

2 ADC

1 × exon 20ins

The other ADC had HER2 (amplification + p.V659E). Affected bilateral breast ductal carcinoma in situ at 29. Did not report family history.

Serra, et al. 2013 [58]

TP53/PMS2

p.V157D/ p.R20Q

40

28

Proband

M

22

Asian

NR

ADC

19del

Family history of a wide variety of tumours (including breast cancer, lung cancer) among family members (affected <=54, half of them < 31 years); father (31, died of colon cancer, K-RAS p.G12D mutation in colon tumour) carried the two germline mutations

Wang, et al. 2014 [59]

APC

c.TCA1110TGA

41

29

Proband

F

43

Asian

NS

ADC

WT

No germline MYH mutations; Somatic K-RAS and p53 wild-type; amplification of three regions 5p, 8q, and 12q14-12q2; affected with FAP at 26, duodenal adenomas at 33. Father with FAP; Son with FAP and medulloblastoma; Paternal great aunt with FAP (whose son was affected with FAP and desmoid tumour, granddaughter with FAP, gastric and thyroid cancer).

Shinmura, et al. 2008 [60]

  1. Abbreviations: AAH atypical adenomatous hyperplasia, ADC adenocarcinoma, AIS adenocarcinoma in situ, BAC bronchioloalveolar carcinoma, F female, FAP familial adenomatous polyposis, GGN ground-glass nodule, LS light smoker, M male, MIA minimally invasive adenocarcinoma, NS never smoker, NSCLC non-small cell lung cancer, S smoker, SCC squamous cell lung cancer, WT wild type. Genes were noted as italics
  2. aThe original publication did not report family history of cancer of the index case, but we included it here due to its diagnosis of familial Li-Fraumeni Syndrome